BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 27844029)

  • 1. Dose-dependent inhibition of demyelination and microglia activation by IVIG.
    Winter M; Baksmeier C; Steckel J; Barman S; Malviya M; Harrer-Kuster M; Hartung HP; Goebels N
    Ann Clin Transl Neurol; 2016 Nov; 3(11):828-843. PubMed ID: 27844029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modified recombinant human IgG1-Fc is superior to natural intravenous immunoglobulin at inhibiting immune-mediated demyelination.
    Baksmeier C; Blundell P; Steckel J; Schultz V; Gu Q; Da Silva Filipe A; Kohl A; Linnington C; Lu D; Dell A; Haslam S; Wang J; Czajkowsky D; Goebels N; Pleass RJ
    Immunology; 2021 Sep; 164(1):90-105. PubMed ID: 33880776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oligodendroglia are protected from antibody-mediated complement injury by normal immunoglobulins ("IVIg").
    Stangel M; Compston A; Scolding NJ
    J Neuroimmunol; 2000 Mar; 103(2):195-201. PubMed ID: 10696915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protection from experimental autoimmune encephalomyelitis by polyclonal IgG requires adjuvant-induced inflammation.
    Quast I; Keller CW; Weber P; Schneider C; von Gunten S; Lünemann JD
    J Neuroinflammation; 2016 Feb; 13():42. PubMed ID: 26893156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polyclonal immunoglobulins (IVIg) modulate nitric oxide production and microglial functions in vitro via Fc receptors.
    Stangel M; Compston A
    J Neuroimmunol; 2001 Jan; 112(1-2):63-71. PubMed ID: 11108934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibodies directed against rubella virus induce demyelination in aggregating rat brain cell cultures.
    Besson Duvanel C; Honegger P; Matthieu JM
    J Neurosci Res; 2001 Sep; 65(5):446-54. PubMed ID: 11536329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Normal polyclonal immunoglobulins ('IVIg') inhibit microglial phagocytosis in vitro.
    Stangel M; Joly E; Scolding NJ; Compston DA
    J Neuroimmunol; 2000 Jul; 106(1-2):137-44. PubMed ID: 10814791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential regulation of myelin phagocytosis by macrophages/microglia, involvement of target myelin, Fc receptors and activation by intravenous immunoglobulins.
    Kuhlmann T; Wendling U; Nolte C; Zipp F; Maruschak B; Stadelmann C; Siebert H; Brück W
    J Neurosci Res; 2002 Jan; 67(2):185-90. PubMed ID: 11782962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular characterization of antibody specificities against myelin/oligodendrocyte glycoprotein in autoimmune demyelination.
    von Büdingen HC; Hauser SL; Fuhrmann A; Nabavi CB; Lee JI; Genain CP
    Proc Natl Acad Sci U S A; 2002 Jun; 99(12):8207-12. PubMed ID: 12060766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of human intravenous immunoglobulin on canine monocytes and lymphocytes.
    Reagan WJ; Scott-Moncrieff C; Christian J; Snyder P; Kelly K; Glickman L
    Am J Vet Res; 1998 Dec; 59(12):1568-74. PubMed ID: 9858408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oligodendrocyte apoptosis and primary demyelination induced by local TNF/p55TNF receptor signaling in the central nervous system of transgenic mice: models for multiple sclerosis with primary oligodendrogliopathy.
    Akassoglou K; Bauer J; Kassiotis G; Pasparakis M; Lassmann H; Kollias G; Probert L
    Am J Pathol; 1998 Sep; 153(3):801-13. PubMed ID: 9736029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of IgE production in vitro by intact and fragmented intravenous immunoglobulin.
    Zhuang Q; Mazer B
    J Allergy Clin Immunol; 2001 Aug; 108(2):229-34. PubMed ID: 11496239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The remyelinating potential and in vitro differentiation of MOG-expressing oligodendrocyte precursors isolated from the adult rat CNS.
    Crang AJ; Gilson JM; Li WW; Blakemore WF
    Eur J Neurosci; 2004 Sep; 20(6):1445-60. PubMed ID: 15355312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of type I IFN signaling on anti-MOG antibody-mediated demyelination.
    Berg CT; Khorooshi R; Asgari N; Owens T
    J Neuroinflammation; 2017 Jun; 14(1):127. PubMed ID: 28646890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antigen-oriented T cell migration contributes to myelin peptide induced-EAE and immune tolerance.
    Zheng P; Fu H; Wei G; Wei Z; Zhang J; Ma X; Rui D; Meng X; Ming L
    Clin Immunol; 2016 Aug; 169():36-46. PubMed ID: 27327113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathogenic myelin oligodendrocyte glycoprotein antibodies recognize glycosylated epitopes and perturb oligodendrocyte physiology.
    Marta CB; Oliver AR; Sweet RA; Pfeiffer SE; Ruddle NH
    Proc Natl Acad Sci U S A; 2005 Sep; 102(39):13992-7. PubMed ID: 16172404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Experimental demyelination caused by primary oligodendrocyte dystrophy. Regional distribution of the lesions in the nervous system of mice [corrected].
    Komoly S
    Ideggyogy Sz; 2005 Jan; 58(1-2):40-3. PubMed ID: 15884397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myelin-reactive antibodies initiate T cell-mediated CNS autoimmune disease by opsonization of endogenous antigen.
    Kinzel S; Lehmann-Horn K; Torke S; Häusler D; Winkler A; Stadelmann C; Payne N; Feldmann L; Saiz A; Reindl M; Lalive PH; Bernard CC; Brück W; Weber MS
    Acta Neuropathol; 2016 Jul; 132(1):43-58. PubMed ID: 27022743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dual roles of the adenosine A2a receptor in autoimmune neuroinflammation.
    Ingwersen J; Wingerath B; Graf J; Lepka K; Hofrichter M; Schröter F; Wedekind F; Bauer A; Schrader J; Hartung HP; Prozorovski T; Aktas O
    J Neuroinflammation; 2016 Feb; 13():48. PubMed ID: 26920550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frontline: Epitope recognition on the myelin/oligodendrocyte glycoprotein differentially influences disease phenotype and antibody effector functions in autoimmune demyelination.
    von Büdingen HC; Hauser SL; Ouallet JC; Tanuma N; Menge T; Genain CP
    Eur J Immunol; 2004 Aug; 34(8):2072-83. PubMed ID: 15259004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.